263 related articles for article (PubMed ID: 12200050)
1. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways.
Grommé M; Neefjes J
Mol Immunol; 2002 Oct; 39(3-4):181-202. PubMed ID: 12200050
[TBL] [Abstract][Full Text] [Related]
2. Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases.
Saveanu L; Fruci D; van Endert P
Mol Immunol; 2002 Oct; 39(3-4):203-15. PubMed ID: 12200051
[TBL] [Abstract][Full Text] [Related]
3. Processing and delivery of peptides presented by MHC class I molecules.
Lehner PJ; Cresswell P
Curr Opin Immunol; 1996 Feb; 8(1):59-67. PubMed ID: 8729447
[TBL] [Abstract][Full Text] [Related]
4. Antigen secreted from noncytosolic Listeria monocytogenes is processed by the classical MHC class I processing pathway.
Zwickey HL; Potter TA
J Immunol; 1999 Jun; 162(11):6341-50. PubMed ID: 10352246
[TBL] [Abstract][Full Text] [Related]
5. Specificity of the proteasome and the TAP transporter.
Uebel S; Tampé R
Curr Opin Immunol; 1999 Apr; 11(2):203-8. PubMed ID: 10322157
[TBL] [Abstract][Full Text] [Related]
6. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
[TBL] [Abstract][Full Text] [Related]
7. A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.
Herberts CA; Stittelaar KJ; van der Heeft E; van Gaans-van den Brink J; Poelen MCM; Roholl PJM; van Alphen LJW; Melief CJM; de Jong APJM; van Els CACM
J Gen Virol; 2001 Sep; 82(Pt 9):2131-2142. PubMed ID: 11514722
[TBL] [Abstract][Full Text] [Related]
8. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules.
Kovacsovics-Bankowski M; Rock KL
Science; 1995 Jan; 267(5195):243-6. PubMed ID: 7809629
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
[TBL] [Abstract][Full Text] [Related]
10. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus.
Lautscham G; Rickinson A; Blake N
Microbes Infect; 2003 Apr; 5(4):291-9. PubMed ID: 12706442
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin.
Gil-Torregrosa BC; Raúl Castaño A; Del Val M
J Exp Med; 1998 Sep; 188(6):1105-16. PubMed ID: 9743529
[TBL] [Abstract][Full Text] [Related]
12. The nature of the MHC class I peptide loading complex.
Cresswell P; Bangia N; Dick T; Diedrich G
Immunol Rev; 1999 Dec; 172():21-8. PubMed ID: 10631934
[TBL] [Abstract][Full Text] [Related]
13. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors.
Luckey CJ; Marto JA; Partridge M; Hall E; White FM; Lippolis JD; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 2001 Aug; 167(3):1212-21. PubMed ID: 11466336
[TBL] [Abstract][Full Text] [Related]
14. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
Delp K; Momburg F; Hilmes C; Huber C; Seliger B
Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
[TBL] [Abstract][Full Text] [Related]
15. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
16. Generation, translocation, and presentation of MHC class I-restricted peptides.
Heemels MT; Ploegh H
Annu Rev Biochem; 1995; 64():463-91. PubMed ID: 7574490
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of MHC class I--restricted antigen processing.
Pamer E; Cresswell P
Annu Rev Immunol; 1998; 16():323-58. PubMed ID: 9597133
[TBL] [Abstract][Full Text] [Related]
18. Antigen-processing machinery breakdown and tumor growth.
Seliger B; Maeurer MJ; Ferrone S
Immunol Today; 2000 Sep; 21(9):455-64. PubMed ID: 10953098
[TBL] [Abstract][Full Text] [Related]
19. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
20. Tapasin-the keystone of the loading complex optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum.
Momburg F; Tan P
Mol Immunol; 2002 Oct; 39(3-4):217-33. PubMed ID: 12200052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
